For decades, people have been dying in their thousands due to cancer. Before any technological advancement in medicine, detecting cancer was left to chance. Although we presently have a lot of medical technological breakthroughs, cancer treatment continues to elude doctors across the globe. The only promising treatment for cancer has been cancer therapy, which can only be applied when the disease gets detected at an early stage. Despite the many challenges encountered, Mikhail Blagosklonny has been left undeterred in his quest to finding a lasting cure for all cancer strains.
As a professorial fellow in Internal Medicine, Experimental Medicine, and Cardiology, Mikhail has become a real expert in matters oncology. Thanks to his innovative mind, Mikhail Blagosklonny has come to a realization that Rapamycin can equally be important in the cure and treatment of cancer. According to Blagosklonny, Rapamycin can also be made use of to slow down the effects of aging. Through his TOR Signaling theory, Mikhail Blagosklonny purports that Rapamycin helps stimulate the growth of stem cells in the body such that they can slow down aging as well as rejuvenate the growth of damaged body cells. Mikhail’s new theory has attracted the attention of many scientists and doctors across the globe since previous studies on the use of stem cells have not proven to be useful until now. Since Blagosklonny has stood out as an expert in mitosis, drug resistance, cell cycle, apoptosis, ontogenesis, tumor suppressors, and anti-cancer therapeutics, his TOR Signaling theory has convinced many.
Currently, Mikhail Blagosklonny is the Professor of Oncology at the Roswell Park Institute, a corporation that he joined back in 2009. Also, Mikhail is renowned as the editor-in-chief of Oncotarget and Cell Cycle. Through the years, Mikhail has been able to become the primary reference point when it comes to Oncology after gaining a lot of experience on the subject. Apart from working for the Roswell Park Cancer Institute, Mikhail Blagosklonny has also been part and parcel of the New York Medical College and the Ordway Research Institute. So far, Mikhail has authored more than 300 pieces centering on clinical investigations, cellular biology, and molecular biology. He has also contributed largely to the content mostly found in PLOS ONE, the American Journal of Pathology. Mr. Blagosklonny has also written content about cell cyclotherpy and chemotherapeutic engineering, with his most favorite subject being Oncology. Check Mikhail’s profile in LinkedIn
Having endured years of trials and research, Mikhail Blagosklonny might as well have given the world the gift of life. Although his TOR Signaling theory is currently undergoing testing, the results have proven to be worthwhile. It is only a matter of time before cancer gets eradicated from the face of the earth, and people given the opportunity to enjoy the gift of being young for as long as they want. Time is coming when the TOR Signaling theory will also be made use of in the treatment and cure of other illnesses. Without Mikhail’s passion for creating a disease-free society, his recent achievements in Oncology would not have been possible.